NR4A1 and breast carcinoma: An earlier study from our group supports an association between OPG and hormone receptor (i.e., estrogen (ER) and progesterone (PR) receptor) negative breast cancer risk [5], though findings from other studies on risk are mixed ([6], reviewed in [7]).